Nicholas Sheridan Lewin Establishment Labs Holdings Inc. (ESTA) insider trading activity

Nicholas Sheridan Lewin is Director of ESTABLISHMENT LABS HOLDINGS INC.. Currently has a direct ownership of 1.08 Million shares of ESTA, which is worth approximately $68.9 Million. The most recent transaction as insider was on Dec 31, 2025, when has been sold 343 shares (Common Shares) at a price of $72.88 per share, resulting in proceeds of $24,997. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 1.08M

0.03% 3M change

0.52% 12M change

Total Value Held $68.9 Million

NICHOLAS SHERIDAN LEWIN Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Dec 31 2025	BUY Grant, award, or other acquisition	$24,997 $72.88 p/Share	343 Added 0.03%	1,076,875 Common Shares
Sep 30 2025	BUY Grant, award, or other acquisition	$24,962 $40.99 p/Share	609 Added 0.06%	1,076,532 Common Shares
Jun 30 2025	BUY Grant, award, or other acquisition	$24,985 $42.71 p/Share	585 Added 0.05%	1,075,923 Common Shares
May 23 2025	BUY Grant, award, or other acquisition	-	3,413 Added 0.32%	1,075,338 Common Shares
Mar 31 2025	BUY Grant, award, or other acquisition	$24,975 $40.81 p/Share	612 Added 0.06%	1,071,925 Common Shares
Dec 31 2024	BUY Grant, award, or other acquisition	$24,969 $46.07 p/Share	542 Added 0.05%	1,071,313 Common Shares
Sep 30 2024	BUY Grant, award, or other acquisition	$24,966 $43.27 p/Share	577 Added 0.05%	1,070,771 Common Shares

Jun 30 2024	BUY Grant, award, or other acquisition	$24,992 $45.44 p/Share	550 Added 0.05%	1,070,194 Common Shares
May 24 2024	BUY Grant, award, or other acquisition	-	2,334 Added 0.22%	1,069,644 Common Shares
Mar 31 2024	BUY Grant, award, or other acquisition	$24,991 $50.9 p/Share	491 Added 0.05%	1,067,310 Common Shares
Dec 31 2023	BUY Grant, award, or other acquisition	$49,993 $25.89 p/Share	1,931 Added 0.18%	1,066,819 Common Shares
Dec 14 2023	BUY Open market or private purchase	$54,000 $27.0 p/Share	2,000 Added 0.19%	1,064,888 Common Shares
Nov 13 2023	BUY Exercise of conversion of derivative security	$4,500,000 $18.0 p/Share	250,000 Added 19.04%	1,062,888 Common Shares
May 28 2023	BUY Grant, award, or other acquisition	-	27,756 Added 3.3%	812,888 Common Shares
May 24 2023	BUY Grant, award, or other acquisition	-	2,324 Added 0.3%	785,132 Common Shares
Jun 17 2022	BUY Grant, award, or other acquisition	-	2,345 Added 0.3%	782,808 Common Shares

Also insider at

CUTR

CUTERA INC Healthcare

Director

ALUR

ALLURION TECHNOLOGIES, INC.

NSL